Related Experiment Videos
Cleavage of structural components of mammalian vitreous by endogenous matrix metalloproteinase-2
1Department of Surgery, Cedars-Sinai Research Institute, Cedars-Sinai Medical Center, University of California at Los Angeles Medical School Affiliate 90048, USA.
Abstract:
Our goal was to determine if the major endogenous vitreous matrix metalloproteinase (MMP-2) could digest known collagenous components of the vitreous body. Matrix metalloproteinase-2 and its associated inhibitors were isolated from porcine vitreous by affinity column chromatography. The inhibitors were inactivated by chemical modification with dithiothreitol and iodoacetamide. The latent MMP-2 was then activated with the organomercurial, p-aminophenyl mercuric acetate (APMA). Bovine vitreous fibrillar collagens (types II, V/XI and IX) were isolated by pepsin extraction and differential salt precipitation. Intact type IX collagen was purified by selective salt precipitation followed by ion exchange and size exclusion chromatography. These isolated collagens were incubated for 6 to 24 h with different concentrations of activated MMP-2, and the extent of collagen degradation was analyzed. Activated MMP-2 was also introduced into freshly isolated vitreous gels and the degree of liquefaction was determined. Our results showed that the activated MMP-2 has no apparent effect upon type II collagen but can degrade type V/XI collagen and type IX collagen fragments (COL2 and COL2 + COL3). In addition, when the type IX collagen was in the intact helical form, MMP-2 appeared to selectively digest alpha 3 (IX) chains. This suggested that vitreous MMP-2 preferentially cleaved certain vitreous collagen chains into large fragments rather than small peptides. MMP-2 also disrupted the vitreous gel in vitro, releasing proteins but not hexuronic acid or sulfated glycosaminoglycans into the liquefied supernatant. We conclude that MMP-2 activity should be considered as a potential mechanism of vitreous liquefaction that is seen in aging and various pathological states.
Insights
Matrix metalloproteinase-2 (MMP-2) can degrade specific collagen types in the vitreous, potentially causing vitreous liquefaction observed in aging and disease.
Area of Science:
- Ophthalmology
- Biochemistry
- Molecular Biology
Background:
- The vitreous body is composed of a collagenous matrix.
- Matrix metalloproteinases (MMPs) are enzymes capable of degrading extracellular matrix components.
- Matrix metalloproteinase-2 (MMP-2) is a major endogenous protease found in the vitreous.
Purpose of the Study:
- To investigate the capacity of endogenous vitreous matrix metalloproteinase-2 (MMP-2) to degrade collagenous components of the vitreous body.
- To determine if MMP-2 activity contributes to vitreous liquefaction.
Main Methods:
- Isolation and purification of matrix metalloproteinase-2 (MMP-2) and its inhibitors from porcine vitreous.
- Activation of latent MMP-2 using p-aminophenyl mercuric acetate (APMA).
- Isolation of bovine vitreous fibrillar collagens (types II, V/XI, and IX) and incubation with activated MMP-2.
- Analysis of collagen degradation and vitreous gel liquefaction in vitro.
Main Results:
- Activated MMP-2 degraded type V/XI collagen and type IX collagen fragments.
- MMP-2 selectively digested alpha 3 (IX) chains of intact helical type IX collagen.
- MMP-2 disrupted vitreous gels in vitro, releasing proteins but not glycosaminoglycans.
Conclusions:
- Vitreous matrix metalloproteinase-2 (MMP-2) preferentially cleaves specific collagen chains, leading to large fragments.
- MMP-2 activity is a potential mechanism driving vitreous liquefaction associated with aging and pathological conditions.
- MMP-2's role in degrading vitreous collagen warrants further consideration in ocular disease pathogenesis.